Automatic extraction of ECG strips from continuous 12-lead Holter recordings for QT analysis at prescheduled versus optimized time points

Annals of Noninvasive Electrocardiology

Volumn 14, Issue SUPPL. 1, 2009, Pages

  Badilini, Fabio ^a   Vaglio, Martino ^a   Sarapa, Nenad ^b  

^a AMPS LLC   (United States)

^b CPCS Pharma Consulting LLC   (United States)

Author keywords

Automated Holter ECG extractions; ECG optimization in thorough QT studies; ECG quality in clinical trials

Indexed keywords

SOTALOL;

ARTICLE; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY MONITORING; HEART RATE; HOLTER MONITORING; HUMAN; NOISE; PRIORITY JOURNAL; QT INTERVAL;

ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY, AMBULATORY; HEART RATE; HUMANS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOFTWARE; SOTALOL;

EID: 58449130444     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00260.x     Document Type: Article

References (13)

1. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). E14 Guidance on Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythic Potential for Non-antiarrythmic Drugs. Available at : http://www.fda.gov/cder/guidance/ 6922fnl.pdf, 2005.
2. Sarapa N. Digital 12-lead Holter in the assessment of drug effects on cardiac repolarization. J Electrocardiol 2006 38 : 293.
3. Badilini F, Maison-Blanche P, Childers R, et al. QT interval analysis on ambulatory recordings: A selective beat averaging approach. Med Bio EngComp 1999 37 : 71 79.
4. Extramiana F, Maison-Blanche P, Haggui A, et al. Control of rapid heart rate changes for electrocardiographic analysis: Implications for thorough QT studies. Clin Cardiol 2006 29 : 534 539.
5. Badilini F. The ISHNE Holter sandard output file format. Ann Noninvasive Electrocardiol 1998 3 : 263 266.
6. Franz MR, Swerdlow CD, Liem LB, et al. Cycle length dependence of human action potential duration in vivo: Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady state frequency. J Clin Invest 1988 82 : 972 979.
7. Pueyo E, Smetana P, Caminal P, et al. Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. IEEE Trans Biomed Eng 2004 51 : 1511 1520.
8. Sun H, Chen P, Hunt J, Malinowski H. Frequency of QT recording and reliability of QT prolongation assessment. Clin Pharm Ther 2004 75 : 48.
9. Sarapa N, Morganroth J, Couderc JP, et al. Electrocardiographic identification of drug-induced QT prolongation: Assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol 2004 9 : 48 57.
10. Couderc JP, Zareba W, Moss A, et al. Identification of sotalol-induced changes in repolarization with T-wave area based repolarization duration parameters. J Electrocardiol 2003 36S : 115 120.
11. Extramiana F, Badilini F, Sarapa N, et al. Contrasting time and rate based approaches for the assessment of drug-induced QT changes. J Clin Pharmacol 2007 47 : 1129 1137.
12. Kligfield P, Badilini F, Brown B, et al. The ISCE Genome Pilot challenge: A 2004 progress report. J Electrocardiol 2004 37S : 144 148.
13. AMPS LLC official web page. Available at : http://www.amps-llc.com/.